Yaobangmang

Benchuziwu Group was founded in August 2015. It is a leading AI company in the health industry and a digital intelligent medical and health ecosystem service platform, recognized as a national high-tech enterprise and a global unicorn enterprise. The Group takes "Industrial AI and Digital Intelligent Supply Chain" as its core new quality productive forces, committed to promoting the upgrading of China's pharmaceutical circulation efficiency and medical service fulfillment system.
The Group operates with a dual-headquarters mechanism in Beijing and Wuhan, and has established more than 30 subsidiaries in Beijing, Hunan, Chongqing, Zhejiang, Shandong and other regions, forming a nationwide business layout. Its two core brands work in synergy to build a full-chain ecological collaboration matrix of "medical + pharmaceutical + insurance":
Xiaoyaoyao (Yaobangmang) serves as the digital intelligent supply chain foundation of the Group's health industry. It holds a B2B pharmaceutical wholesale license approved by the National Medical Products Administration, and has built a digital full-chain service system covering "source seeking and procurement—intelligent warehousing—efficient logistics—convenient sales—flexible financing." The platform cooperates with over 10,000 upstream pharmaceutical enterprises and more than 4 million SKUs, empowering over 500,000 physical pharmacies and primary medical institutions nationwide, firmly ranking in the top tier of domestic pharmaceutical B2B supply chains.
Heye Health is committed to reshaping the entire life cycle of commercial health insurance and medical payment through artificial intelligence and digital supply chains. Relying on its proprietary "medical insurance risk control large model," a nationwide "full-domain pharmaceutical direct payment network," and a tri-rights-integrated industrial fulfillment network (including self-built internet hospitals, 295 pharmaceutical smart cloud factories, and 60,000 cooperative pharmacies), it provides insurance institutions and large enterprise customers with full-stack solutions, from actuarial pricing, intelligent triage, and second-level claim review to direct payment and fulfillment for medical and pharmaceutical services. This leads commercial health insurance into a new era of controllable costs, measurable claims, and a closed-loop service system.
The Group has completed multiple rounds of financing involving top institutions such as Tencent, Sequoia Capital China, and Source Code Capital. Looking to the future, Benchuziwu Group will closely follow the strategic theme of "Healthy China," continuously empower the industrial upgrading of pharmaceutical circulation and health insurance ecosystems, and bring high-quality medical and health services to every household.